Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.784 USD | +4.65% | +3.10% | +1.96% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 22.1M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.86
x | P/E ratio 2025 * |
-0.99
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81% |
Latest transcript on Lisata Therapeutics, Inc.
1 day | +4.65% | ||
1 week | +3.10% | ||
Current month | -10.78% | ||
1 month | -12.28% | ||
3 months | -1.99% | ||
6 months | +35.13% | ||
Current year | +1.96% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.784 | +4.65% | 3 987 |
24-04-25 | 2.66 | -6.01% | 6,093 |
24-04-24 | 2.83 | +6.79% | 9,625 |
24-04-23 | 2.65 | -0.75% | 13,395 |
24-04-22 | 2.67 | -1.11% | 1,894 |
Delayed Quote Nasdaq, April 26, 2024 at 11:51 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.96% | 22.1M | |
+1.82% | 42.59B | |
+8.09% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+9.40% | 24.81B | |
-24.27% | 18.17B | |
+28.47% | 12.05B | |
-3.16% | 11.7B | |
+7.02% | 11.1B |
- Stock Market
- Equities
- LSTA Stock